{
    "title": "Biohaven's drug for neurological disease fails late-stage study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10845405/Biohavens-drug-genetic-neurological-disease-fails-late-stage-study.html",
    "date": "2022-05-23",
    "keywords": [
        "drug",
        "disease",
        "study",
        "biohaven",
        "monday",
        "ataxia",
        "goal",
        "change",
        "troriluzole",
        "placebo",
        "company",
        "fda",
        "system",
        "latestage",
        "sca",
        "disorder",
        "degeneration",
        "brain",
        "cord",
        "movement",
        "muscle",
        "severity",
        "baseline",
        "week",
        "treatment",
        "group",
        "progression",
        "significance",
        "benefit",
        "type",
        "form",
        "share",
        "data",
        "subtype",
        "food",
        "administration",
        "path",
        "forward",
        "month",
        "pfizer",
        "inc",
        "deal",
        "confidence",
        "marketing",
        "application",
        "zavegepant",
        "nasal",
        "spray",
        "migraine",
        "decision",
        "quarter",
        "reporting",
        "leo",
        "amruta",
        "khandekar",
        "bengaluru",
        "editing",
        "aditya",
        "soni"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}